TrialDiabetes, obesity & metabolism2018

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin.

Stefano Del Prato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.